Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This piece is part of the PlexusDx Education Hub, our evidence-first resource on GLP-1 medications, weight management protocols, and the genetics that influence them. Browse all Peptides & GLP-1 education
The following is independent editorial analysis. PlexusDx has no commercial relationship with Henry Meds or Orderly Health, runs no affiliate links, and is not compensated for either mention.
Full head-to-head: PlexusDx vs Henry Meds →
Someone searching "Henry Meds vs Orderly Health meds" wants the medication picture: which GLP-1 formulations each program can prescribe and how those get dispensed. This editorial centers on that — formulations, compounded-versus-brand routing, and the 503A pathway — then adds the genetic variable neither company screens. As of April 2026 many programs exist; we focus on these two.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
What "meds" really means in these programs
Both Henry Meds and Orderly Health can put a GLP-1 in your hands, but the medication you receive depends on a chain of decisions: eligibility at intake, whether a brand-name product or a compounded formulation is routed, and which pharmacy fills it. Understanding that chain matters more than the logo on the app.
How Orderly Health dispenses
Orderly Health runs on telehealth paired with a compounded-pharmacy pathway. A provider evaluates the virtual intake and, when appropriate, prescribes; a licensed compounding pharmacy fills it. Medication menus and program terms vary and change, so consult Orderly Health's official website for current specifics whenever you evaluate it.
How Henry Meds dispenses
Henry Meds also combines virtual evaluation with compounded dispensing, routing either brand-name FDA-approved GLP-1 products or compounded semaglutide and tirzepatide through licensed compounding pharmacies. Present medication details live on Henry Meds's official website.
The 503A compounding pathway, explained
Compounded GLP-1 formulations in this model come from 503A compounding pharmacies, which prepare medications for individual patients under a prescription. That is a different regulatory route from mass-manufactured FDA-approved brand products. Which route a program uses affects formulation, format (injectable versus oral), and availability. Pricing across GLP-1 telehealth in 2026 commonly runs from roughly $200 to $700 or more per month once program fees, medication, and dispensing are counted; because Henry Meds and Orderly Health each publish their own figures, verify current medication pricing on each brand's site before deciding.
Formulation aside, the compound is the pharmacology
The active molecule, not the dispensing brand, sets the drug's action. GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide work on appetite, satiety, and gastric emptying. The evidence lives with the compounds: STEP for semaglutide in weight management (NEJM 2021), SURMOUNT for tirzepatide (NEJM 2022), and SURMOUNT-OSA for tirzepatide in obstructive sleep apnea (NEJM 2024). Effects vary by dose, molecule, and individual.
The genetic input missing from every prescription
No medication pathway, compounded or brand, accounts for the inherited biology a GLP-1 drug meets. GLP1R encodes the receptor these compounds target, FTO influences fat-mass and obesity risk, MC4R governs satiety and energy balance, and TCF7L2 ties to glucose control and GLP-1 secretion. These pathway-level variants describe terrain rather than predict response. PlexusDx pairs its Weight Management Protocols — Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral — with the Precision Peptide Genetic Test, which reads 14 pathways, 49 peptides, 150+ genetic insights across FTO, MC4R, and TCF7L2. That is the test before you invest logic: map the biology, then choose a medication with your provider.
Not affiliated: PlexusDx has no affiliation with Henry Meds or Orderly Health and no commercial tie to any company reviewed here.
Related reading on PlexusDx: GLP 1 Receptor Agonist, GLP 1 Drugs, GLP 1 Hormone, What Is GLP 1.
Disclaimer: This article is educational. PlexusDx is not affiliated with Henry Meds or Orderly Health and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols — this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways; it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.
Compare the PlexusDx medication approach: see the Weight Management Protocols or begin with the Precision Peptide Genetic Test.
Frequently Asked Questions
Which GLP-1 medications do Henry Meds and Orderly Health prescribe?
Both can prescribe GLP-1 receptor agonists such as semaglutide, and dual GIP/GLP-1 agonists such as tirzepatide, subject to clinical eligibility. Whether you receive a brand-name or compounded formulation depends on the routing at intake. Check each program's current medication menu on its own site.
What is a 503A compounded GLP-1?
A 503A compounding pharmacy prepares medication for an individual patient under a prescription, rather than mass-manufacturing it. Compounded semaglutide or tirzepatide follows this route. It differs from FDA-approved brand products in regulatory pathway and availability, which is why programs describe dispensing carefully during intake.
Does the Precision Peptide Genetic Test choose a medication for me?
No. It does not predict response to any compound or to Henry Meds or Orderly Health. It reports pathway-level variants in FTO and MC4R, and TCF7L2 that describe baseline GLP-1 biology — context for a conversation with your provider, not a prescription recommendation.
How does PlexusDx handle medication differently?
PlexusDx dispenses semaglutide and tirzepatide through its Weight Management Protocols and pairs them with the Precision Peptide Genetic Test. The difference is pathway-level genetic context on FTO, MC4R variants, which medication-dispensing programs like Henry Meds and Orderly Health do not include.
This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Henry Meds and Wegovy: Semaglutide Options and Program Model
Henry Meds vs LifeMD: Subscription vs Compounded GLP-1